IL6 and early-onset autosomal dominant Alzheimer disease: Studies have shown that in the course of Alzheimer’s disease, cells that are sensitive to IL-6 shed from their surface the receptors that are responsible for binding this cytokine, leading to a decrease in its activity and abolition of its pro-inflammatory effect on neurons in AD patients [113].